Treace Medical Concepts, Inc.
NASDAQ:TMCI
8.04 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -49.527 | -42.815 | -20.552 | -3.668 | -4.265 |
| Depreciation & Amortization
| 5.352 | 2.133 | 0.685 | 1.21 | 0.793 |
| Deferred Income Tax
| 15.982 | 0 | 0.419 | 2.143 | 0.145 |
| Stock Based Compensation
| 17.352 | 8.111 | 3.409 | 0.919 | 0.815 |
| Change In Working Capital
| -9.743 | -5.809 | -1.33 | -5.319 | -5.308 |
| Accounts Receivables
| -9.301 | -11.039 | -4.226 | -4.291 | -6.022 |
| Inventory
| -9.848 | -8.769 | -3.088 | -3.402 | -2.813 |
| Accounts Payables
| 3.167 | 4.612 | 1.791 | 1.334 | -0.236 |
| Other Working Capital
| 6.239 | 9.387 | 4.193 | 1.04 | 3.763 |
| Other Non Cash Items
| -13.991 | 7.732 | 0.176 | 0.221 | 0.147 |
| Operating Cash Flow
| -34.575 | -30.648 | -17.193 | -4.494 | -7.673 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -11.458 | -14.838 | -2.705 | -1.069 | -1.211 |
| Acquisitions Net
| -20 | 61.68 | 0 | 0 | 0 |
| Purchases Of Investments
| -169.865 | -63.409 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 120.024 | 1.729 | 0 | 0 | 0 |
| Other Investing Activites
| -49.841 | -61.68 | 0 | 0 | 0 |
| Investing Cash Flow
| -81.299 | -76.518 | -2.705 | -1.069 | -1.211 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 109.396 | 2.187 | 109.44 | 0.364 | 0.068 |
| Common Stock Repurchased
| -0.013 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.013 | 52.512 | 107.652 | 31.139 | 39.342 |
| Financing Cash Flow
| 109.383 | 20.806 | 107.652 | 11.503 | 19.739 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -6.491 | -86.36 | 87.754 | 5.94 | 10.855 |
| Cash At End Of Period
| 12.982 | 19.473 | 105.833 | 18.079 | 12.139 |